Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 27, 2024 -- An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept. 24 in JAMA Network Open.
Claire M. Starling, M.P.H., from the MedStar Health Research Institute in Washington, D.C., and colleagues assessed the efficacy of a CBT-informed, voice-activated, internet-delivered program for improving insomnia symptoms among breast cancer survivors. The analysis included 70 breast cancer survivors with insomnia who were randomly assigned (1:1) to a smart speaker with a voice-interactive CBT-insomnia (CBT-I) program or educational control for six weeks.
The researchers found that from baseline to follow-up, Insomnia Severity Index scores changed by a mean of −8.4 points in the intervention group versus −2.6 in the control group. Sleep quality, as assessed by diary data, showed statistically significant improvements in the intervention group versus the control group, as did wake after sleep onset (9.54 minutes), sleep onset latency (8.32 minutes), and sleep efficiency (−0.04 percent). However, there was no improvement in total sleep time.
"Future studies should explore potential for scaling in-home sleep programs and increasing application of artificial intelligence and should compare engagement and noninferiority with other effective CBT-I programs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Behavior Change Intervention Via Mail Cuts Use of Sleep Medications in Older Adults
FRIDAY, Sept. 20, 2024 -- A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with...
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
THURSDAY, Sept. 19, 2024 -- For patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a...
DBT Increases Cancer Detection Versus Digital Mammography
THURSDAY, Sept. 19, 2024 -- Digital breast tomosynthesis (DBT) can increase cancer detection compared with two-dimensional digital mammography (DM), according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.